BioSpace News Archive

Business

Pain Therapeutics Reports Third Quarter 2017 Financial Results

The Company still expects net cash usage in the calendar year 2017 may be approximately $10 million.

November 1, 2017

·

8 min read

Business

Sarah Steele Chang Joins Bioz as VP of Sales

Chang will be responsible for the management of all sales efforts and the growth and development of Bioz’s sales teams.

November 1, 2017

·

2 min read

Genetown

Takeda to Showcase Data That May Reshape the Future of Blood Cancer Treatments During 59th ASH Annual Meeting

Eleven Takeda-sponsored abstracts were accepted for presentation during ASH 2017.

November 1, 2017

·

41 min read

Genetown

Syros to Present Initial Clinical Data from Ongoing Phase 2 Clinical Trial of SY-1425 and New Preclinical Data on SY-1365 at ASH Annual Meeting

Syros today announced that initial clinical data from the ongoing Phase 2 trial of SY-142 will be presented at the ASH Annual Meeting and Exposition taking place December 9-12 in Atlanta.

November 1, 2017

·

6 min read

Biotech Bay

Elizabeth Iorns, Ph.D., CEO and Co-Founder of Science Exchange, Named 2017 Scrip Award Executive of the Year Finalist

Dr. Iorns is one of six C-level executives recognized in the Executive of the Year category for private companies or those with a market capitalization of <$1 billion.

November 1, 2017

·

3 min read

Jaguar Health Subsidiary Napo Pharmaceuticals Launches New Website for Mytesi, Napo’s FDA-Approved, First-in-Class Anti-Secretory Human Prescription Drug

Jaguar Health announced today that its wholly-owned subsidiary, Napo Pharmaceuticals, Inc. (Napo), has launched a significantly enhanced version of Mytesi.com, the website for Mytesi® (crofelemer),

November 1, 2017

·

3 min read

BioMidwest

Navidea to Present Late-Breaking Abstract at American College of Rheumatology Annual Meeting

CSO of Navidea, will present a poster of an abstract, titled, “Evaluation of Intravenous Injection of Tc 99m Tilmanocept in Static Planar Gamma Emission Imaging and Fused SPECT/CT Imaging for Rheumatoid Arthritis” and provide an overview of Navidea’s development pipeline.

November 1, 2017

·

4 min read

Pharm Country

Alexion Release: New Phase I/II Study Data for ALXN1210 As a Potential Future Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) to Be Presented at ASH Meeting

Alexion Pharmaceuticals announced today that researchers will present new data from two Phase 1/2 clinical studies of ALXN1210.

November 1, 2017

·

12 min read

Philips Wins FDA Nod for Small Parts Ultrasound Tr

FDA

Intellijoint Surgical Nabs FDA OK for Revision THA With Intellijoint HIP

Intellijoint’s milestone supports Intellijoint Surgical’s mission of making intellijoint HIP accessible to every surgeon and every patient.

November 1, 2017

·

2 min read

Drug Development

Symic Bio Announces Results From the Phase I//I SHIELD Trial of SB-030 in Peripheral Vascular Disease

In a first-in-human, prospective, randomized, single-blind controlled study of 67 patients, SB-030 demonstrated a positive safety profile, with no clinically meaningful difference observed in adverse events between treatment and control groups.

November 1, 2017

·

5 min read